Evaluation and Treatment of Adult Growth Hormone Deficiency: An Endocrine Society Clinical Practice Guideline
Authors:
- For The Endocrine Society’s Clinical Guidelines SubcommitteeFSFor The Endocrine Society’s Clinical Guidelines Subcommittee
Open Access
- 1 May 2006
- journal article
- guideline
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 91 (5) , 1621-1634
Abstract
The objective is to provide guidelines for the evaluation and treatment of adults with GH deficiency (GHD). The chair of the Task Force was selected by the Clinical Guidelines Subcommittee of The Endocrine Society (TES). The chair selected five other endocrinologists and a medical writer, who were approved by the Council. One closed meeting of the group was held. There was no corporate funding, and members of the group received no remuneration. Only fully published, peer-reviewed literature was reviewed. The Grades of Evidence used are outlined in the Appendix. Consensus was achieved through one group meeting and e-mailing of drafts that were written by the group with grammatical/style help from the medical writer. Drafts were reviewed successively by the Clinical Guidelines Subcommittee, the Clinical Affairs Committee, and TES Council, and a version was placed on the TES web site for comments. At each level, the writing group incorporated needed changes. GHD can persist from childhood or be newly acquired. Confirmation through stimulation testing is usually required unless there is a proven genetic/structural lesion persistent from childhood. GH therapy offers benefits in body composition, exercise capacity, skeletal integrity, and quality of life measures and is most likely to benefit those patients who have more severe GHD. The risks of GH treatment are low. GH dosing regimens should be individualized. The final decision to treat adults with GHD requires thoughtful clinical judgment with a careful evaluation of the benefits and risks specific to the individual.Keywords
This publication has 118 references indexed in Scilit:
- The effect of long‐term untreated growth hormone deficiency (GHD) and 9 years of GH replacement on the quality of life (QoL) of GH‐deficient adultsClinical Endocrinology, 2002
- Individualized dose titration of growth hormone (GH) during GH replacement in hypopituitary adultsClinical Endocrinology, 1997
- Normal growth hormone secretion in growth hormone insufficient children retested after completion of linear growthClinical Endocrinology, 1996
- The prevalence of severe growth hormone deficiency in adults who received growth hormone replacement in childhoodClinical Endocrinology, 1996
- Which adults develop side‐effects of growth hormone replacement?Clinical Endocrinology, 1995
- Benign intracranial hypertension in children with growth hormone deficiency treated with growth hormoneThe Journal of Pediatrics, 1995
- Diagnosis of growth-hormone deficiency in adultsThe Lancet, 1994
- The Effects of Treatment with Recombinant Human Growth Hormone on Body Composition and Metabolism in Adults with Growth Hormone DeficiencyNew England Journal of Medicine, 1989
- Growth hormone state after completion of treatment with growth hormone.Archives of Disease in Childhood, 1987
- Familial holoprosencephaly with endocrine dysgenesisThe Journal of Pediatrics, 1968